Factor List | Mazurek2015 (10056)


Factors

Title Description Host Host Type Outcomes
Duration of trimethoprim-sulfamethoxazole use P2 (7-wk-old cohort, sampled after 2 wks of AMU) P1 (6-wk-old cohort, sampled after 1 wk of AMU). Metaphylactic treatment with trimethoprim-sulfamethoxazole as medicated fodder, 15–30 mg active substance/1 kg body weight/day, to post-weaning piglets. Swine Weaners 2
Duration of trimethoprim-sulfamethoxazole use P2 (7-wk-old cohort, sampled after 2 wks of AMU) P1 (6-wk-old cohort, sampled after 1 wk of AMU). Metaphylactic treatment: trimethoprim-sulfamethoxazole as medicated fodder, 15–30 mg active substance/1 kg bw/day, to post-weaning piglets. Swine Weaners 7
Duration of trimethoprim-sulfamethoxazole use P3 (8-wk-old cohort, sampled after 3 wks of AMU) P1 (6-wk-old cohort, sampled after 1 wk of AMU). Metaphylactic treatment with trimethoprim-sulfamethoxazole as medicated fodder, 15–30 mg active substance/1 kg body weight/day, to post-weaning piglets. Swine Weaners 2
Duration of trimethoprim-sulfamethoxazole use P3 (8-wk-old cohort, sampled after 3 wks of AMU) P1 (6-wk-old cohort, sampled after 1 wk of AMU). Metaphylactic treatment: trimethoprim-sulfamethoxazole as medicated fodder, 15–30 mg active substance/1 kg bw/day, to post-weaning piglets. Swine Weaners 7
Duration of trimethoprim-sulfamethoxazole use S2 (Sows 18 weeks after end of treatment, these are 6 month old first parity sows) vs S1 (Sows 10 weeks after end of treatment, these are 4.5 month old gilts). These herds were subjected to the same metaphylactic program when they were post-weaning piglet Swine Sows 2